§ Mr. BurstowTo ask the Secretary of State for Health (1) what assessment he has made of NICE's provision appraisal determination estimate for implementing a positive guidance on beta interferon and glatiramer acetate; [8710]
(2) what assessment he has made of NICE's Provisional Appraisal Determination estimate for implementing positive guidance on beta interferon and glatiramer acetate. [9416]
§ Ms BlearsWe are currently holding discussions with the manufacturers to consider a range of options under which drugs for multiple sclerosis might be made available under the national health service. One option is a 'risk-sharing' scheme which will evaluate their clinical and cost effectiveness, and until these discussions are concluded we cannot provide the information requested.